Novel mechanisms of the antiproliferative effects of amlodipine in vascular smooth muscle cells from spontaneously hypertensive rats

Hypertension Research

Volumn 25, Issue 1, 2002, Pages 109-115

  Lai, Yi Mu ^a   Fukuda, Noboru ^a   Su, Jin Zi ^a   Suzuki, Ryo ^a   Ikeda, Yukihiro ^a   Takagi, Hiroto ^a   Tahira, Yoshiko ^a   Kanmatsuse, Kanmatsuse ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amlodipine; Growth factor; Phenotypic modulation; Proliferation; Vascular smooth muscle cells

Indexed keywords

AMLODIPINE; ANGIOTENSIN; BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; DNA; MATRIX G1A PROTEIN; MESSENGER RNA; NIFEDIPINE; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR A; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DNA SYNTHESIS; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HYPERTENSION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

AMLODIPINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CELL DIVISION; CELLS, CULTURED; GROWTH SUBSTANCES; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; PHENOTYPE; RATS; RATS, INBRED SHR; RNA, MESSENGER;

EID: 0036191677     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.109     Document Type: Article

References (37)

1. Molecular mechanisms of the exaggerated growth of vascular smooth muscle cells in hypertension
2. Vascular smooth muscle cell hyperresponsiveness to growth factors in hypertension
3. Transforming growth factor β1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats
4. Stimulation of autocrine platelet-derived growth factor AA-homodimer and transforming growth factor b in vascular smooth muscle cells
5. Bunazosin hydrochloride inhibits exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats by suppressing the response to growth factors
6. Participation of proteolysis and transforming growth factor β1 activation in growth of cultured smooth muscle cells from spontaneously hypertensive rats
7. Antisense oligodeoxynucleotide complementary to PDGF A-chain mRNA inhibits the arterial proliferation in spontaneously hypertensive rats without alterating their blood pressures
8. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats
9. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats
10. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats
11. Pharmacologic profile of amlodipine
12. Results and clinical implications of the CAPARES trial
13. Disparate effects of calcium antagonists on renal microcirculation
14. The smooth muscle cell II: Growth of smooth muscle in culture and formation of elastic fibers
15. An increase in adenylate cyclase activity precedes DNA synthesis in cultured vascular smooth muscle cells
16. Results and clinical implications of the CAPARES trial
17. Limits of lipid-lowering therapy: The benefits of amlodipine as an anti-atherosclerotic agent
18. 2+ pool content is linked to control of cell growth
19. Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells
20. Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle
21. Induction of calcium currents by the expression of the alpha 1-subunit of the dihydropyridine receptor from skeletal muscle
22. Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kB in primary human vascular smooth muscle cells
23. Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation
24. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts: Evidence for thrombin-induced signals different from phosphoinositide turnover and inhibition
25. The inhibitory mechanisms of amlodipine in human vascular smooth muscle cell proliferation
26. Amlodipine enhances NO production induced by an ACE inhibitor through a kinin-mediated mechanism in canine coronary microvessels
27. Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent
28. NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: Implications for vascular growth arrest
29. Smooth muscle cell phenotypes in atherosclerotic lesions
30. The smooth muscle cell in culture
31. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells
32. Identification of osteoglycin as a component of the vascular matrix: Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques
33. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats
34. The pathogenesis of atherosclerosis: Atherogenesis and inflammation
35. Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: An electron-microscopic and stereological study
36. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats
37. The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation